These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Transport via the transcytotic pathway makes prostasin available as a substrate for matriptase. Friis S; Godiksen S; Bornholdt J; Selzer-Plon J; Rasmussen HB; Bugge TH; Lin CY; Vogel LK J Biol Chem; 2011 Feb; 286(7):5793-802. PubMed ID: 21148558 [TBL] [Abstract][Full Text] [Related]
4. Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity. Szabo R; Hobson JP; List K; Molinolo A; Lin CY; Bugge TH J Biol Chem; 2008 Oct; 283(43):29495-504. PubMed ID: 18713750 [TBL] [Abstract][Full Text] [Related]
5. Differential subcellular localization renders HAI-2 a matriptase inhibitor in breast cancer cells but not in mammary epithelial cells. Chang HH; Xu Y; Lai H; Yang X; Tseng CC; Lai YJ; Pan Y; Zhou E; Johnson MD; Wang JK; Lin CY PLoS One; 2015; 10(3):e0120489. PubMed ID: 25786220 [TBL] [Abstract][Full Text] [Related]
6. The intracellular seven amino acid motif EEGEVFL is required for matriptase vesicle sorting and translocation to the basolateral plasma membrane. Tseng CC; Jia B; Barndt RB; Dai YH; Chen YH; Du PA; Wang JK; Tang HJ; Lin CY; Johnson MD PLoS One; 2020; 15(2):e0228874. PubMed ID: 32049977 [TBL] [Abstract][Full Text] [Related]
7. The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin. Friis S; Sales KU; Schafer JM; Vogel LK; Kataoka H; Bugge TH J Biol Chem; 2014 Aug; 289(32):22319-32. PubMed ID: 24962579 [TBL] [Abstract][Full Text] [Related]
8. Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition. Wang JK; Lee MS; Tseng IC; Chou FP; Chen YW; Fulton A; Lee HS; Chen CJ; Johnson MD; Lin CY Am J Physiol Cell Physiol; 2009 Aug; 297(2):C459-70. PubMed ID: 19535514 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of an active zymogen protease: the zymogen form of matriptase is regulated by HAI-1 and HAI-2. Skovbjerg S; Holt-Danborg L; Nonboe AW; Hong Z; Frost ÁK; Schar CR; Thomas CC; Vitved L; Jensen JK; Vogel LK Biochem J; 2020 May; 477(9):1779-1794. PubMed ID: 32338287 [TBL] [Abstract][Full Text] [Related]
10. Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development. Szabo R; Molinolo A; List K; Bugge TH Oncogene; 2007 Mar; 26(11):1546-56. PubMed ID: 16983341 [TBL] [Abstract][Full Text] [Related]
11. Matriptase Complexes and Prostasin Complexes with HAI-1 and HAI-2 in Human Milk: Significant Proteolysis in Lactation. Lai CH; Lai YJ; Chou FP; Chang HH; Tseng CC; Johnson MD; Wang JK; Lin CY PLoS One; 2016; 11(4):e0152904. PubMed ID: 27043831 [TBL] [Abstract][Full Text] [Related]
12. Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein. Mitchell AC; Kannan D; Hunter SA; Parra Sperberg RA; Chang CH; Cochran JR J Biol Chem; 2018 Apr; 293(14):4969-4980. PubMed ID: 29386351 [TBL] [Abstract][Full Text] [Related]
13. HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease. Oberst MD; Chen LY; Kiyomiya K; Williams CA; Lee MS; Johnson MD; Dickson RB; Lin CY Am J Physiol Cell Physiol; 2005 Aug; 289(2):C462-70. PubMed ID: 15800053 [TBL] [Abstract][Full Text] [Related]
14. Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1. Kirchhofer D; Peek M; Li W; Stamos J; Eigenbrot C; Kadkhodayan S; Elliott JM; Corpuz RT; Lazarus RA; Moran P J Biol Chem; 2003 Sep; 278(38):36341-9. PubMed ID: 12815039 [TBL] [Abstract][Full Text] [Related]
15. Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase. Kojima K; Tsuzuki S; Fushiki T; Inouye K J Biol Chem; 2008 Feb; 283(5):2478-87. PubMed ID: 18048349 [TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor activator inhibitor type 1 inhibits protease activity and proteolytic activation of human airway trypsin-like protease. Kato M; Hashimoto T; Shimomura T; Kataoka H; Ohi H; Kitamura N J Biochem; 2012 Feb; 151(2):179-87. PubMed ID: 22023801 [TBL] [Abstract][Full Text] [Related]
17. Simultaneous activation and hepatocyte growth factor activator inhibitor 1-mediated inhibition of matriptase induced at activation foci in human mammary epithelial cells. Lee MS; Kiyomiya K; Benaud C; Dickson RB; Lin CY Am J Physiol Cell Physiol; 2005 Apr; 288(4):C932-41. PubMed ID: 15590895 [TBL] [Abstract][Full Text] [Related]
19. Selective Inhibition of Prostasin in Human Enterocytes by the Integral Membrane Kunitz-Type Serine Protease Inhibitor HAI-2. Shiao F; Liu LO; Huang N; Lai YJ; Barndt RJ; Tseng CC; Wang JK; Jia B; Johnson MD; Lin CY PLoS One; 2017; 12(1):e0170944. PubMed ID: 28125689 [TBL] [Abstract][Full Text] [Related]
20. Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1. Denda K; Shimomura T; Kawaguchi T; Miyazawa K; Kitamura N J Biol Chem; 2002 Apr; 277(16):14053-9. PubMed ID: 11805118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]